On December 31, 2025, the Securities Issue Committee of NACL Industries Limited (NACLIND) approved the allotment of 3,25,01,851 fully paid-up equity shares under its recently concluded Rights Issue. NACL Industries is a listed subsidiary of Coromandel International Limited (CIL).
Key Highlights of the Rights Issue Allotment
The equity shares, having a face value of ₹1 each, were issued at a price of ₹76.70 per share, which includes a premium of ₹75.70 per share. The allotment was carried out in accordance with the terms outlined in the Letter of Offer and was made to eligible shareholders and renouncees.
Coromandel International’s Participation
Coromandel International Limited fully subscribed to its Rights Entitlement and also applied for additional shares. As a result, CIL was allotted 1,88,24,301 equity shares on a cash consideration basis. These shares will be credited to Coromandel’s demat account within the timelines prescribed by SEBI.
Shareholding Impact
Following the allotment, Coromandel International’s total holding in NACL Industries increased from 10,69,12,581 shares to 12,57,36,882 shares. This has led to an increase in its ownership stake from 53.06% to 53.73%, further strengthening Coromandel’s controlling interest in the subsidiary.
About NACL Industries Limited
NACL Industries is a well-established player in the agrochemical sector, engaged in the manufacture and sale of crop protection technicals and formulations. Its product portfolio includes insecticides, herbicides, fungicides, and other agricultural solutions. For the financial year ended March 31, 2025, the company reported a standalone turnover of ₹1,251.89 crore.
Strategic Significance
The increased investment allows Coromandel International to consolidate its control over NACL Industries while supporting the subsidiary’s capital requirements and long-term growth plans within the agrochemical segment.